Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Only Medics

Only Medics is a specialist international medical recruitment company that focuses exclusively on the recruitment of pharmaceutical physicians for pharmaceutical companies, biotechnology companies, Clinical Research Organisations (CROs) and Regulatory Authorities. We successfully recruit on both a contingent and retained basis on permanent positions as well as interim medical assignments. Our geographic reach is truly global and although our main focus is the European job market, we also recruit for pharmaceutical physician jobs in the US, Canada, Australia and Asia Pacific.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Digital communications, Medical education, Recruitment and career development

Company Details

Only Medics
7-11 Station Road, Reading, RG1 1LG, United Kingdom
+44 (0)118 9522 799
Contact Only Medics
Website

 Latest Content from PMHub 

IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

Press Releases | September 27, 2016 | Lucid Group Communications Limited

Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

Artificial Intelligence: the new healthcare algorithm

White Papers and Resources | September 27, 2016 | Blue Latitude Health

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare....

Lucid Group becomes a sponsor of MedComms Networking

Press Releases | September 23, 2016 | Lucid Group Communications Limited

To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...

Showcasing our multichannel capabilities in Berlin

White Papers and Resources | September 22, 2016 | Anthill Agency

Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications

DAM and CMS: managing assets to maximise adoption and value

White Papers and Resources | September 19, 2016 | Blue Latitude Health

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised...

Tenth Lucid Academy module delivered – nurturing talent and driving excellence

Press Releases | September 15, 2016 | Lucid Group Communications Limited

Celebrating the success of the Lucid Academy

Lucid launch new recruitment campaign to attract top talent in medical writing

Press Releases | September 8, 2016 | Lucid Group Communications Limited

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Press Releases | September 7, 2016 | Lucid Group Communications Limited

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

How to enable each healthcare professional to fully understand your product

White Papers and Resources | September 7, 2016 | Anthill Agency

Read these three articles to understand how working at an individual level benefits all customers:

Alzheimer’s disease: reviewing the immediate treatment horizon

White Papers and Resources | September 1, 2016 | Blue Latitude Health

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.